Drug given to President Trump for COVID-19, Studied at Willis-Knighton

·

·

Drug given to President Trump for COVID-19, Studied at Willis-Knighton

The Regeneron Experimental Antibody Treatment (REGN-COV2) administered to the president after he tested positive for COVID-19 is being studied as part of clinical trials for treatment of the virus by Willis-Knighton Physician Network Clinical Research in …
See Original Article

Missouri breaks COVID-19 hospitalization record for 12th straight day

ST. LOUIS (KMOV.com) — Missouri’s COVID-19 hospitalizations have been on a steady increase, breaking new records for 12 days in a row reaching 1,163 Saturday, according to the state’s health department. The state recently updated its coronavirus …
See Original Article

Global Real Estate Accounting Software Market: Size, Share, Technological Advancement …

Global Real Estate Accounting Software Market: Size, Share, Technological Advancement & Growth Analysis with Forecast to 2027. October 4, 2020. 5
See Original Article

Germany Warns of Nationalism Risks 30 Years After Reunification

(Bloomberg) — Germany warned that nationalism risks undermining the international political system, which helped pave the way for the country's
See Original Article

Visitation Policy To Change Within Eastern CT Hospitals Amid COVID-19 Outbreak

CONNECTICUT, USA — All inpatient and outpatient locations of Eastern Connecticut, Backus, Windham, and Natchaug hospitals are implementing new visitor restrictions due to recent outbreaks in the community. The visitor restrictions were set in place after …
See Original Article



Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.